Alcon switches Pataday eye allergy drops in US

19 February 2020 - Deborah Wilkes


Alcon is launching two OTC versions of its Pataday (olopatadine hydrochloride) eye allergy drops in the US after the US Food and Drug Administration (FDA) approved a switch from prescription-to-OTC status for the medicines.

Click tags below for more information on topics:


Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to Industry News

Share this page: